116 related articles for article (PubMed ID: 20795456)
1. HPV vaccine for prevention of cervical cancer: key issues and challenges for developing countries.
JNMA J Nepal Med Assoc; 2009; 48(175):I-II. PubMed ID: 20795456
[No Abstract] [Full Text] [Related]
2. Introducing HPV vaccine in developing countries--key challenges and issues.
Agosti JM; Goldie SJ
N Engl J Med; 2007 May; 356(19):1908-10. PubMed ID: 17494923
[No Abstract] [Full Text] [Related]
3. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
Goldie SJ; O'Shea M; Diaz M; Kim SY
Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
[TBL] [Abstract][Full Text] [Related]
4. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
Ault K; Reisinger K
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
6. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
Mahdavi A; Monk BJ
Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
[TBL] [Abstract][Full Text] [Related]
7. U.S. girls to receive HPV vaccine but picture unclear on potential worldwide use, acceptance.
Twombly R
J Natl Cancer Inst; 2006 Aug; 98(15):1030-2. PubMed ID: 16882936
[No Abstract] [Full Text] [Related]
8. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
[TBL] [Abstract][Full Text] [Related]
9. [Vaccination against cervical cancer and diseases caused by Human Papillomavirus].
Bornstein J; Tuma R; Zarfati D; Ophir E
Harefuah; 2007 Oct; 146(10):764-9, 814. PubMed ID: 17990391
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
11. HPV prevention update. New vaccine offers additional options.
Klisz C; Kaplan C
Adv Nurse Pract; 2009 Nov; 17(11):28-9, 54. PubMed ID: 20014688
[No Abstract] [Full Text] [Related]
12. Cervical cancer prevention in the human papilloma virus vaccine era.
Ghazal-Aswad S
Ann N Y Acad Sci; 2008 Sep; 1138():253-6. PubMed ID: 18837904
[TBL] [Abstract][Full Text] [Related]
13. Comment on "New paradigm for prevention of cervical cancer" [Eur J Obstet Gynecol Reprod Biol 2007;130(1):25-9].
Mahajan NN; Gaikwad NL; Soni RN; Mahajan KN
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):140-1; author reply 141. PubMed ID: 17524549
[No Abstract] [Full Text] [Related]
14. The role of the human papillomavirus (HPV) vaccine in developing countries.
Kling M; Zeichner JA
Int J Dermatol; 2010 Apr; 49(4):377-9. PubMed ID: 20465688
[TBL] [Abstract][Full Text] [Related]
15. Latin America. Price is the main barrier to wider use of papillomavirus vaccine.
Kaiser J
Science; 2008 May; 320(5878):860. PubMed ID: 18487164
[No Abstract] [Full Text] [Related]
16. [Introduction of vaccination against human papillomavirus in developing countries: update and perspectives].
Hessel L
Med Trop (Mars); 2009 Aug; 69(4):323-6. PubMed ID: 19725378
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
Saslow D; Wheeler CM
Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
[TBL] [Abstract][Full Text] [Related]
18. Mathematical model of HPV provides insight into impacts of risk factors and vaccine.
Kim JJ
PLoS Med; 2006 May; 3(5):e164. PubMed ID: 16573363
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus quadrivalent vaccine: a look behind the numbers.
Flaherty DK; Alkhateeb FM
Ann Pharmacother; 2009 Apr; 43(4):740-4. PubMed ID: 19276314
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV) infection, cervical cancer and vaccination against HPV: a Nordic perspective.
Kjaer SK
Acta Obstet Gynecol Scand; 2007; 86(11):1286-9. PubMed ID: 17963055
[No Abstract] [Full Text] [Related]
[Next] [New Search]
